Journal
EUROPEAN RESPIRATORY JOURNAL
Volume 37, Issue 2, Pages 238-243Publisher
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00146509
Keywords
Chronic obstructive pulmonary disease; smoking; spirometry; vitamin D
Categories
Funding
- Minnesota Medical Foundation [3857-9227-08]
- National Institutes of Health [K12 RR023247, UL1 RR024150]
Ask authors/readers for more resources
Low blood vitamin D levels have been postulated to be a risk factor for worse lung function, based largely on cross-sectional data. We sought to use longitudinal data to test the hypothesis that baseline plasma 25-hydroxyvitamin D (25(OH) D) is lower in subjects with more rapid lung function decline, compared to those with slow lung function decline. We conducted a nested, matched case-control study in the Lung Health Study 3 cohort. Cases and controls were continuous smokers with rapid and slow lung function decline, respectively, over similar to 6 yrs of follow-up. We compared baseline 25(OH) D levels between cases and controls, matching date of phlebotomy and clinical centre. Among 196 subjects, despite rapid and slow decliners experiencing strikingly and significantly different rates of decline of forced expiratory volume in 1 s (-152 versus -0.3 mL.yr(-1); p<0.001), there was no significant difference in baseline 25(OH) D levels (25.0 versus 25.9 ng.mL(-1); p=0.54). There was a high prevalence of vitamin D insufficiency (35%) and deficiency (31%); only 4% had a normal 25(OH) D level in the winter. Although vitamin D insufficiency and deficiency are common among continuous smokers with established mild-to-moderate chronic obstructive pulmonary disease, baseline 25(OH) D levels are not predictive of subsequent lung function decline.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available